First Trust Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8M | Sell |
1,104,044
-495,192
| -31% | -$17.8M | 0.03% | 658 |
|
|
2025
Q1 | $49.8M | Buy |
1,599,236
+800,728
| +100% | +$24.9M | 0.04% | 535 |
|
|
2024
Q4 | $20.4M | Sell |
798,508
-157,472
| -16% | -$4.02M | 0.02% | 854 |
|
|
2024
Q3 | $27M | Buy |
955,980
+51,544
| +6% | +$1.46M | 0.03% | 696 |
|
|
2024
Q2 | $23.8M | Buy |
904,436
+879,632
| +3,546% | +$23.2M | 0.02% | 723 |
|
|
2024
Q1 | $753K | Sell |
24,804
-161,392
| -87% | -$4.9M | ﹤0.01% | 2049 |
|
|
2023
Q4 | $5.23M | Buy |
186,196
+171,249
| +1,146% | +$4.81M | 0.01% | 1237 |
|
|
2023
Q3 | $406K | Buy |
+14,947
| New | +$406K | ﹤0.01% | 2188 |
|
|
2023
Q2 | – | Sell |
-10,462
| Closed | -$377K | – | 2434 |
|
|
2023
Q1 | $377K | Sell |
10,462
-118,157
| -92% | -$4.26M | ﹤0.01% | 2192 |
|
|
2022
Q4 | $5.08M | Sell |
128,619
-18,751
| -13% | -$741K | 0.01% | 1187 |
|
|
2022
Q3 | $5.92M | Sell |
147,370
-164,748
| -53% | -$6.62M | 0.01% | 1123 |
|
|
2022
Q2 | $13.1M | Buy |
312,118
+2,236
| +0.7% | +$94K | 0.02% | 855 |
|
|
2022
Q1 | $12.1M | Sell |
309,882
-182,912
| -37% | -$7.13M | 0.01% | 985 |
|
|
2021
Q4 | $19.6M | Buy |
492,794
+37,900
| +8% | +$1.51M | 0.02% | 847 |
|
|
2021
Q3 | $16.4M | Sell |
454,894
-32,128
| -7% | -$1.16M | 0.02% | 846 |
|
|
2021
Q2 | $20M | Sell |
487,022
-52,884
| -10% | -$2.17M | 0.02% | 777 |
|
|
2021
Q1 | $23.6M | Sell |
539,906
-67,209
| -11% | -$2.93M | 0.03% | 656 |
|
|
2020
Q4 | $30.4M | Buy |
+607,115
| New | +$30.4M | 0.04% | 514 |
|